A. Davis

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment

Uthaug, M. V., Lancelotta, R., Szabo, A., Davis, A. K., Riba, J., & Ramaekers, J. G. | Psychopharmacology | 10 December 2019

By OPEN|2020-02-24T19:55:21+02:0010 December 2019|Tags: A. Davis, A. Szabo, J. Ramaekers, J. Riba, M. Uthaug, R. Lancelotta|

Cessation and reduction in alcohol consumption and misuse after psychedelic use

Garcia-Romeu, A., Davis, A. K., Erowid, F., Erowid, E., Griffiths, R. R., & Johnson, M. W. | Journal of Psychopharmacology | 14 May 2019

By OPEN|2019-06-24T15:12:37+02:0014 May 2019|Tags: A. Davis, A. Garcia-Romeu, E. Erowid, F. Erowid, M. Johnson, R. Griffiths|

Survey of subjective “God encounter experiences”: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT.

Griffiths, R. R., Hurwitz, E. S., Davis, A. K., Johnson, M. W., & Jesse, R. | PloS one | 23 April 2019

By OPEN|2019-08-10T16:38:52+02:0023 April 2019|Tags: A. Davis, E. Hurwitz, M. Johnson, R. Griffiths, R. Jesse|

5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety

Davis, A. K., So, S., Lancelotta, R., Barsuglia, J. P., & Griffiths, R. R.| The American journal of drug and alcohol abuse | 1 March 2019

By OPEN|2019-03-13T12:20:26+02:001 March 2019|Tags: A. Davis, J. Barsuglia, R. Griffiths, R. Lancelotta, S. So|

Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study

Barsuglia, J. P., Davis, A. K., Palmer, R., Lancelotta, R., Windham-Herman, A. M., Peterson, K., ... & Griffiths, R. R. | Frontiers in psychology | 06 December 2018

By OPEN|2019-01-26T16:50:41+02:006 December 2018|Tags: A. Davis, A. Windham-Herman, J. Barsuglia, K. Peterson, R. Griffiths, R. Lancelotta, R. Palmer|

Intensity of Mystical Experiences Occasioned by 5-MeO-DMT and Comparison With a Prior Psilocybin Study

Barsuglia, J. P., Davis, A. K., Palmer, R., Lancelotta, R., Windham-Herman, A. M., Peterson, K., ... & Griffiths, R. R. | Frontiers in psychology | 6 December 2018

By OPEN|2019-04-24T12:29:08+02:006 December 2018|Tags: A. Davis, A. Windham-Herman, J. Barsuglia, K. Peterson, R. Griffiths, R. Lancelotta, R. Palmer|

A Mixed-Method Analysis of Persisting Effects Associated with Positive Outcomes Following Ibogaine Detoxification

Davis, A. K., Renn, E., Windham-Herman, A. M., Polanco, M., & Barsuglia, J. P. | Journal of psychoactive drugs | 18 July 2018

By OPEN|2019-03-21T20:08:04+02:0018 July 2018|Tags: A. Davis, A. Windham-Herman, E. Renn, J. Barsuglia, M. Polanco|

The epidemiology of 5-methoxy- N,N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. | Journal of Psychopharmacology | 30 April 2018

By OPEN|2018-11-02T13:22:29+02:0030 April 2018|Tags: A. Davis, E. Renn, J. Barsuglia, R. Grant, R. Lancelotta|

The epidemiology of 5-methoxy-N, N-dimethyltryptamine (5-MeO-DMT) use: Benefits, consequences, patterns of use, subjective effects, and reasons for consumption

Davis, A. K., Barsuglia, J. P., Lancelotta, R., Grant, R. M., & Renn, E. | Journal of Psychopharmacology | 30 April 2018

By OPEN|2018-09-06T11:31:27+02:0030 April 2018|Tags: A. Davis, E. Renn, J. Barsuglia, R. Grant, R. Lancelotta|

Subjective effectiveness of ibogaine treatment for problematic opioid consumption: Short- and long-term outcomes and current psychological functioning

Davis, A. K., Barsuglia, J. P., Windham-Herman, A. M., Lynch, M., & Polanco, M. | Journal of Psychedelic Studies | 17 October 2017

By OPEN|2017-11-06T17:45:03+02:0017 October 2017|Tags: A. Davis, A. Windham-Herman, J. Barsuglia, M. Lynch, M. Polanco|